Biogen’s (BIIB) Buy Rating Reaffirmed at Cantor Fitzgerald
Cantor Fitzgerald restated their buy rating on shares of Biogen (NASDAQ:BIIB) in a research report report published on Wednesday morning. The brokerage currently has a $400.00 price target on the biotechnology...
Aerospace & Defense
Flight Attendants Accuse Frontier Airlines of Not Allowing Breast Feeding
More »
- Spirit Airlines Cancellations Cause Chaos in Airport
- China’s C919 Completes Maiden Flight
- United Earnings Meet Expectations, But Fall 52%
- Air France to Launch No-Frills Airline For U.S. and Asia
- Delta’s Profit for Second Quarter Rises But Revenue Falls
- Boeing Announces Historic Deal with Iran Air
- JetBlue Planning Mint Service Expansion After Losing Virgin America Bid
- Southwest Wants to Fly Out of Long Beach
Banking
Biogen’s (BIIB) Buy Rating Reaffirmed at Cantor Fitzgerald
More »
- Farmers National Banc (FMNB) Upgraded to Hold by Zacks Investment Research
- NextEra Energy (NEE) Price Target Raised to $193.00 at Credit Suisse Group
- Dave & Buster’s Entertainment (PLAY) Price Target Cut to $58.00 by Analysts at Jefferies Financial Group
- Embers (MBRS) Achieves Market Capitalization of $46,389.00
- InflationCoin Reaches Market Capitalization of $76,200.00 (IFLT)
- HCA Healthcare (HCA) Rating Increased to Buy at Zacks Investment Research
- Emergent Biosolutions (EBS) Given a $75.00 Price Target by Cantor Fitzgerald Analysts
- Jefferies Financial Group Lowers RPC (RES) to Sell
Pharmaceuticals
Shares at Radius Jump as Bone Drug of Amgen Has Setback
More »
- FDA Approves New Treatment for ALS
- Valeant Pharmaceuticals Cuts Debt Following L’Oreal Deal
- FDA Gives Approval to New Powerful Eczema Drug
- Trump Tweet Sends Pharmaceutical Stocks Tumbling
- Shares of Kite Pharma Flying High After Reaching Study Goal
- Pharmaceuticals Shunning Push by Trump for FDA Shift
- Cigna Changes to Generic EpiPen, CVS Cuts Prices
- Pfizer and OPKO Drug for Growth Hormone Deficiency Fails Study
Goods & Commodities
Hyundai and Kia Recall Ordered by South Korea Officials
More »
- Mattel CEO Promises Growth Following Sales Slump
- Burberry Misses Estimates on Sales
- Tesla Deliveries Set Record for One Quarter at 25,000
- FedEx Comes Up Short on Earnings
- Brazil Looks to Calm Fears Over Export and Sale of Meat
- Dollar General Increasing Pay, Lowering Price and Adding Perishable Goods
- Shares of Staples Fall After Earnings Come Up Short
- Opel Sold by General Motors to PSA
Technology
What’s next for technology in entertainment?
More »
- How to Become a Java Developer – Practical Guide
- Super Nintendo World Theme Park Officially Starts Construction
- Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
- Camera Zooms In and Can Recognize Faces
- Netflix Could See 150 Million Worldwide Subscribers
- LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
- Blackberry Returns as Stock Surges Following WannaCry
- General Motors’ Maven Launches in New York City
Energy & Mining
Fuel Shortage in Venezuela Growing Worse
More »
- Oil Prices Drop to Low of Three Months on Rig Count
- The 2016 oil market: a year in review
- What’s next for the oil market as it reaches a critical point?
- Exxon Issues Warning on Reserves After Posting Drop in Profit
- Shell Posts Disappointing Results As Profit Hit by BG Deal and Oil
- DONG Energy Stock Surges After Largest European IPO in 2016
- SunEdison Said to be Preparing to File Bankruptcy
- West Virginia Gives Tax Break to Natural Gas and Coal
Free Email Newsletter
Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:
Follow Ticker Report
Recent Posts
- Biogen’s (BIIB) Buy Rating Reaffirmed at Cantor Fitzgerald
- Farmers National Banc (FMNB) Upgraded to Hold by Zacks Investment Research
- NextEra Energy (NEE) Price Target Raised to $193.00 at Credit Suisse Group
- Dave & Buster’s Entertainment (PLAY) Price Target Cut to $58.00 by Analysts at Jefferies Financial Group
- Embers (MBRS) Achieves Market Capitalization of $46,389.00
- InflationCoin Reaches Market Capitalization of $76,200.00 (IFLT)
- HCA Healthcare (HCA) Rating Increased to Buy at Zacks Investment Research
- Emergent Biosolutions (EBS) Given a $75.00 Price Target by Cantor Fitzgerald Analysts
- Jefferies Financial Group Lowers RPC (RES) to Sell
- National Bank Financial Begins Coverage on Extendicare (EXETF)
- Spotify (SPOT) Shares Bought by Vista Equity Partners Management LLC
- Weber Alan W Raises Position in Gain Capital Holdings Inc (GCAP)
- Worldquant Millennium Quantitative Strategies LLC Has $35.02 Million Position in F5 Networks, Inc. (FFIV)
- Worldquant Millennium Quantitative Strategies LLC Has $26.69 Million Stake in Palo Alto Networks Inc (PANW)
- Humana Inc (HUM) Shares Bought by Worldquant Millennium Quantitative Strategies LLC
- PTC (PMTC) Given Outperform Rating at Wedbush
- 40,899 Shares in Invesco Zacks Mid-Cap ETF (CZA) Acquired by EP Wealth Advisors LLC
- EP Wealth Advisors LLC Raises Stake in Allergan plc (AGN)
- Farr Miller & Washington LLC DC Has $30.06 Million Position in United Technologies Co. (UTX)
- AC3 (AC3) Price Up 0.1% Over Last 7 Days
© 2006-2018 Ticker Report